Equities

Nano-X Imaging Ltd

NNOX:NMQ

Nano-X Imaging Ltd

Actions
Health CareMedical Equipment and Services
  • Price (USD)6.16
  • Today's Change0.270 / 4.58%
  • Shares traded3.27k
  • 1 Year change0.00%
  • Beta2.0016
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments827889
Total Receivables, Net1.480.981.05
Total Inventory2.36----
Prepaid expenses1.272.413.13
Other current assets, total1.141.451.97
Total current assets898295
Property, plant & equipment, net474539
Goodwill, net--7.4258
Intangibles, net8191102
Long term investments--2568
Note receivable - long term------
Other long term assets2.162.871.06
Total assets219254363
LIABILITIES
Accounts payable3.303.623.13
Accrued expenses4.78134.49
Notes payable/short-term debt000.15
Current portion long-term debt/capital leases3.49----
Other current liabilities, total3.958.4845
Total current liabilities162553
Total long term debt03.483.80
Total debt3.493.483.94
Deferred income tax2.953.337.06
Minority interest------
Other liabilities, total4.665.377.41
Total liabilities233771
SHAREHOLDERS EQUITY
Common stock0.170.160.15
Additional paid-in capital516478439
Retained earnings (accumulated deficit)(320)(259)(146)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.31)(1.97)(0.61)
Total equity196217292
Total liabilities & shareholders' equity219254363
Total common shares outstanding585552
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.